Figure 2From: Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinomaHeatmap representation of VEGF, M2PK, and ANGPT2 plasma levels by patient, over time. For each marker and patient, values were normalized to the number of standard deviations above (red) of below (blue) the average. Samples are arranged in chronological order for each patient. The number of samples available for each patient varies, and isolated gray boxes for a particular patient represent missing values for the particular analysis.Back to article page